Vida Icon Vida Logo
  • Home
  • About Us
  • Team
  • Portfolio
  • News
  • Investors
  • Fellowship
  • Contact

Author carolvidaadmin

11 June 2025

Capstan Therapeutics Announces Initiation of Phase 1 Trial of Lead In Vivo CAR-T Therapy, CPTX2309, for Treating Autoimmune Disease

read more
10 June 2025

Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases

read more
28 May 2025

Aktis Oncology Initiates Phase 1b Clinical Trial Of Its Nectin-4- Targeting Radiopharmaceutical Product Candidate, Aky-1189, Across Multiple Tumor Types

read more
23 May 2025

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

read more
2 April 2025

Vida Ventures Taps Industry Heavyweights from JP Morgan and MPM BioImpact to Further Power Leadership Team

read more
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 20
  • Older

Tweets

Tweets by vidaventures

Transforming biomedical innovations into therapies

Make a meaningful difference in patients’ lives

© 2025 Vida Ventures, LLC

  • Home
  • About Us
  • Team
  • Portfolio
  • News
  • Investors
  • Fellowship
  • Contact
Top